Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,614 signal articles · 195 in last 24h · 117,232 total before filter · latest 1h ago
195last 24h
1652last 7d
266● bullish (7d)
150● bearish (7d)
205publishers
AllMacro310Earnings730M&A96Regulatory25Product12Analyst24
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Roivant Sciences Q1 Earnings Call Highlights
MarketBeat11d agoneutral
Roivant Sciences Q1 Earnings Call Highlights

Roivant Sciences (NASDAQ:ROIV) said it expects a busy second half of 2026, with a potential launch of brepocitinib in dermatomyositis, several clinical readouts and additional regulatory discussions across its pipeline. Chief Executive Officer Matt Gline characterized the quarter as relatively quie

B. Riley Financial Q2 Earnings Call Highlights
MarketBeat11d agoneutral
B. Riley Financial Q2 Earnings Call Highlights

B. Riley Financial (NASDAQ:RILY) reported second-quarter net income attributable to common shareholders of $19 million, or $0.45 per diluted share, as its capital markets, wealth management and communications businesses contributed to what Chairman, Founder and Co-CEO Bryant Riley called the company

Rigetti Computing Q2 Earnings Call Highlights
MarketBeat11d agoneutral
Rigetti Computing Q2 Earnings Call Highlights

Rigetti Computing (NASDAQ:RGTI) reported second-quarter 2026 revenue of approximately $5.1 million, up from $1.8 million a year earlier, as the quantum computing company recognized revenue from previously announced on-premises Novera quantum processing unit purchase orders. Chief Executive Officer

REGENXBIO Q2 Earnings Call Highlights
MarketBeat11d agoneutral
REGENXBIO Q2 Earnings Call Highlights

REGENXBIO (NASDAQ:RGNX) reported second-quarter 2026 progress across its late-stage gene-therapy pipeline, highlighting completed enrollment in its Duchenne muscular dystrophy confirmatory study, an agreed path to resubmit its Hunter syndrome therapy application, and the start of a pivotal diabetic

Red Cat Q2 Earnings Call Highlights
MarketBeat11d agoneutral
Red Cat Q2 Earnings Call Highlights

Red Cat (NASDAQ:RCAT) reported second-quarter 2026 revenue of $20.2 million, up 520% from $3.2 million a year earlier, as deliveries across its drone portfolio and defense programs increased. The company said revenue for the first six months of 2026 reached $35.7 million, compared with $4.8 million

Wix.com (WIX) Stock Still Looks Cheap On Fresh AI Earnings Momentum
Simply Wall St.11d agoneutral
Wix.com (WIX) Stock Still Looks Cheap On Fresh AI Earnings Momentum

Wix.com stock has been under pressure for years, with the share price down about 71.0% over the past 5 years, yet the current valuation checks still flag it as looking cheap on several measures. The roughly 71.0% share price decline over 5 years means long-term holders have seen a significant loss in value that the recent rebound has only partially offset. Investor focus is now on whether Wix.com's AI driven products and recent partnership plans can support sustained revenue growth, while...

CVS Health (CVS) Is Down 8.6% After Raising 2026 Guidance And Expanding GLP-1 Tie-Up With Lilly – Has The Bull Case Changed?
Simply Wall St.11d agoneutral
CVS Health (CVS) Is Down 8.6% After Raising 2026 Guidance And Expanding GLP-1 Tie-Up With Lilly – Has The Bull Case Changed?

In early August 2026, CVS Health reported second-quarter results showing higher sales of US$35,117 million and revenue of US$106.10 billion, alongside net income of US$2,979 million and materially higher earnings per share versus a year earlier. On the same day, CVS Health also raised its 2026 earnings guidance and expanded its GLP-1 weight management offering through a new collaboration with Eli Lilly, underscoring how integrated pharmacy, insurance and care-delivery assets can be combined...

PubMatic Q2 Earnings Call Highlights
MarketBeat11d agoneutral
PubMatic Q2 Earnings Call Highlights

PubMatic (NASDAQ:PUBM) reported second-quarter revenue growth of 11% year over year, returning to double-digit growth ahead of its prior expectations, as the company cited momentum in connected TV, mobile applications and AI-powered products. Adjusted EBITDA rose 38% from a year earlier to $19.6 mi

Paramount Skydance Q2 Earnings Call Highlights
MarketBeat11d agoneutral
Paramount Skydance Q2 Earnings Call Highlights

Paramount Skydance (NASDAQ:PSKY) said its second-quarter performance reflected progress in its efforts to expand streaming, rebuild its studios business and reduce costs, while management reaffirmed confidence in the company’s proposed combination with Warner Bros. Discovery. Chairman and Chief Exe

Unusual Machines (UMAC) Reports Q2 Losses, Is The Upside Already Priced In?
Simply Wall St.11d agoneutral
Unusual Machines (UMAC) Reports Q2 Losses, Is The Upside Already Priced In?

Unusual Machines (UMAC) reported its second quarter 2026 results on August 6, with sales of US$16.72 million and a net loss of US$7.78 million, bringing first half net income to US$2.5 million. See our latest analysis for Unusual Machines. The earnings release comes after a strong run for Unusual Machines, with a 90 day share price return of 80.55% and a 1 year total shareholder return of 152.66%. However, the share price slipped 5.83% on the day of the results as investors reassessed near...

PENN Entertainment Q2 Earnings Call Highlights
MarketBeat11d agoneutral
PENN Entertainment Q2 Earnings Call Highlights

PENN Entertainment (NASDAQ:PENN) reported record second-quarter retail revenue and raised its full-year outlook for the segment, while management said its interactive business continued to narrow losses through lower marketing spending, cost efficiencies and growth in online casino operations. Chie

Palladyne AI Q2 Earnings Call Highlights
MarketBeat11d agoneutral
Palladyne AI Q2 Earnings Call Highlights

Palladyne AI (NASDAQ:PDYN) reported second-quarter revenue of $5.8 million, a company record that rose 63% sequentially and 470% from a year earlier, as it cited growth across its precision manufacturing, avionics, engineering services and AI development activities. The company reaffirmed its 2026

Ouster Q2 Earnings Call Highlights
MarketBeat11d agoneutral
Ouster Q2 Earnings Call Highlights

Ouster (NASDAQ:OUST) reported second-quarter revenue of $55 million, up approximately 56% from a year earlier, as demand from industrial and smart-infrastructure customers helped the lidar and perception technology company ship a record number of sensors. Chief Executive Officer Angus Pacala said t

Ocugen Q2 Earnings Call Highlights
MarketBeat11d agoneutral
Ocugen Q2 Earnings Call Highlights

Ocugen (NASDAQ:OCGN) said its second quarter marked progress across its late-stage ophthalmology pipeline, including FDA clearance to begin a Phase III study of OCU410 in geographic atrophy and an RMAT designation for the program. Chairman, Chief Executive Officer and Co-Founder Shankar Musunuri sa

Novavax Q2 Earnings Call Highlights
MarketBeat11d agoneutral
Novavax Q2 Earnings Call Highlights

Novavax (NASDAQ:NVAX) reported second-quarter 2026 revenue of $57 million and a net loss of $53 million, while highlighting progress in its Sanofi partnership, expanding use of its Matrix-M adjuvant platform and continued cost reductions. Revenue declined from $239 million a year earlier, primarily

Insight Enterprises Q2 Earnings Call Highlights
MarketBeat11d agoneutral
Insight Enterprises Q2 Earnings Call Highlights

Insight Enterprises (NASDAQ:NSIT) reported second-quarter results that exceeded its expectations, with broad-based growth in hardware, cloud and services helping drive operating leverage. The company raised its full-year outlook for gross profit growth and adjusted diluted earnings per share while o

IPG Photonics (IPGP) Earnings Put Its Recovery Story And Valuation Back In Focus
Simply Wall St.11d agoneutral
IPG Photonics (IPGP) Earnings Put Its Recovery Story And Valuation Back In Focus

What IPG Photonics’ Latest Earnings Mean For Investors IPG Photonics (IPGP) reported second quarter 2026 earnings on 4 August, with higher sales but lower net income and earnings per share. The company also issued third quarter revenue guidance of US$265 million to US$295 million. See our latest analysis for IPG Photonics. Since the start of 2026, IPG Photonics has delivered a 15.85% year to date share price return, although recent momentum has faded, with the share price down 10.25% over 30...

Motorola Solutions (MSI) Is Up 10.0% After Raising 2026 Guidance On Record Backlog And Buybacks – Has The Bull Case Changed?
Simply Wall St.11d agobullish
Motorola Solutions (MSI) Is Up 10.0% After Raising 2026 Guidance On Record Backlog And Buybacks – Has The Bull Case Changed?

Motorola Solutions recently reported past second-quarter 2026 results with revenue of US$3,133 million and net income of US$557 million, alongside a new fixed-rate senior unsecured bond offering and a small US$1 million fixed-asset impairment. The company also raised its full-year 2026 revenue guidance to about US$12.98 billion, supported by a record US$15.60 billion backlog and continued share repurchases under its long-running buyback program. Now we will examine how the raised full-year...